SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-145166
Filing Date
2017-04-28
Accepted
2017-04-28 07:02:32
Documents
9
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d279122ddefa14a.htm DEFA14A 27234
2 GRAPHIC g279122na02.jpg GRAPHIC 24228
3 GRAPHIC g279122na04.jpg GRAPHIC 14089
4 GRAPHIC g279122na05.jpg GRAPHIC 7311
5 GRAPHIC g279122na06.jpg GRAPHIC 2605
6 GRAPHIC g279122na07.jpg GRAPHIC 3852
7 GRAPHIC g279122na08.jpg GRAPHIC 5641
8 GRAPHIC g279122naa1_2.jpg GRAPHIC 41684
9 GRAPHIC g279122snap0004.jpg GRAPHIC 3030
  Complete submission text file 0001193125-17-145166.txt   170127
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35945 | Film No.: 17791627
SIC: 2834 Pharmaceutical Preparations